**Exhibit
        31.2**
 **CERTIFICATION
        PURSUANT TO**
 **18
        U.S.C. SECTION 1350,**
 **AS
        ADOPTED PURSUANT TO**
 **SECTION
        302 OF THE SARBANES-OXLEY ACT OF 2002**
 
 I,
        Philip E. Barak, Chief Financial Officer certify that:
 
 1. I
        have reviewed this quarterly report on Form 10-QSB of Flagship Global Health,
        Inc. (the "Registrant");
 
 2. Based
        on my knowledge, this report does not contain any untrue statement of a material
        fact or omit to state a material fact necessary to make the statements made,
        in
        light of the circumstances under which such statements were made, not misleading
        with respect to the period covered by this report;
 
 3. Based
        on my knowledge, the financial statements, and other financial information
        included in this report, fairly present in all material respects the financial
        condition, results of operations and cash flows of the Registrant as of,
        and
        for, the periods presented in this report;
 
 4. The
        Registrant's other certifying officer and I are responsible for establishing
        and
        maintaining disclosure controls and procedures (as defined in Exchange Act
        Rules
        13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
        defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the Registrant
        and
        have:
 
 (a) Designed
        such disclosure controls and procedures, or caused such disclosure controls
        and
        procedures to be designed under our supervision, to ensure that material
        information relating to the Registrant ,
        including its consolidated subsidiaries, is made known to us by others within
        those entities, particularly during the period in which this report is being
        prepared ;
  (b) Evaluated
        the effectiveness of the Registrant 's
        disclosure controls and procedures and presented in this report our conclusions
        about the effectiveness of the disclosure controls and procedures, as of
        the end
        of the period covered by this report based on such evaluation; and
  (c) Disclosed
        in this report any change in the Registrant 's
        internal control over financial reporting that occurred during the Registrant 's
        most recent fiscal quarter (the Registrant 's
        fourth fiscal quarter in the case of an annual report) that has materially
        affected, or is reasonably likely to materially affect, the Registrant 's
        internal control over financial reporting; and
 
 5. The
        Registrant's other certifying officer and I have disclosed, based on our
        most
        recent evaluation of internal control over financial reporting, to the
        Registrant's auditors and the audit committee of the Registrant's board of
        directors (or persons performing the equivalent functions):
 
 (a) All
        significant deficiencies and material weaknesses in the design or operation
        of
        internal control over financial reporting which are reasonably likely to
        adversely affect the Registrant's ability to record, process, summarize and
        report financial information; and
 
 (b) Any
        fraud, whether or not material, that involves management or other employees
        who
        have a significant role in the Registrant's internal control over financial
        reporting.
 
 Date: August 13, 2007/s/ Philip
                  E.
                  BarakPhilip E. Barak, Chief Financial
                  Officer